Stryker Corp. | Cash Flow

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,006
515
1,439
1,647
1,020
3,553
Depreciation, Depletion & Amortization
307
378
397
546
642
723
Other Funds
13
32
32
30
128
158
Funds from Operations
1,490
1,997
2,339
2,402
2,006
2,852
Changes in Working Capital
396
215
1,440
590
447
242
Net Operating Cash Flow
1,886
1,782
899
1,812
1,559
2,610
Capital Expenditures
195
233
270
490
598
Purchase/Sale of Investments
298
729
2,379
634
183
Net Investing Cash Flow
2,217
1,878
1,956
4,191
1,712
Cash Dividends Paid - Total
401
462
521
568
636
Issuance/Reduction of Debt, Net
1,005
1,159
48
2,912
299
Net Financing Cash Flow
300
629
1,141
2,361
695
Net Change in Cash
56
456
1,584
63
774
Free Cash Flow
1,691
1,549
629
1,322
961
Deferred Taxes & Investment Tax Credit
23
60
87
46
36
1,582
Net Assets from Acquisitions
2,320
916
153
4,332
930
Change in Capital Stock
317
100
700
13
230
Exchange Rate Effect
25
77
130
45
74
Other Uses
-
-
-
3
1

About Stryker

View Profile
Address
2825 Airview Boulevard
Kalamazoo Michigan 49002
United States
Employees -
Website http://www.stryker.com
Updated 07/08/2019
Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems.